Journal of Nuclear Medicine

From Compassionate Use Toward High-Level Evidence for Radiopharmaceutical Therapy in Recurrent Meningioma: The LUMEN-1 and MOMENTUM-1 Trials

Theranostics and radiopharmaceutical therapies are rapidly transforming the medical landscape, and the neuro-oncology community is observing these developments with great interest. In a field characte ...
snmjournals.org

Biodistribution and Radiation Dosimetry of

Journal of Nuclear Medicine September 2025, jnumed.125.270267; DOI: https://doi.org/10.2967/jnumed.125.270267 ...
snmjournals.org

CXCR4 PET/CT Predicts Left Ventricular Recovery 8 Months After Acute Myocardial Infarction

Journal of Nuclear Medicine September 2025, jnumed.125.270807; DOI: https://doi.org/10.2967/jnumed.125.270807 ...
snmjournals.org

Evaluation of a Sensitive Visual Read Algorithm for Assessing 3R/4R Tau PET Images

Journal of Nuclear Medicine September 2025, jnumed.125.269685; DOI: https://doi.org/10.2967/jnumed.125.269685 ...
snmjournals.org

Combining PSMA-Targeted Radiopharmaceutical Therapy with Immunotherapy

Journal of Nuclear Medicine August 2025, jnumed.125.270317; DOI: https://doi.org/10.2967/jnumed.125.270317 ...
snmjournals.org

Evaluating Radiotheranostic Targets for Endometrial Cancer

Journal of Nuclear Medicine August 2025, jnumed.125.270318; DOI: https://doi.org/10.2967/jnumed.125.270318 ...
snmjournals.org

CD24 as a Novel Radiopharmaceutical Target for Hepatocellular Carcinoma

Journal of Nuclear Medicine July 2025, jnumed.125.270167; DOI: https://doi.org/10.2967/jnumed.125.270167 ...
snmjournals.org

Assessing Interlesional Tumor Response and Patient Outcomes with Sequential PSMA PET/CT in Metastatic Castration-Resistant Prostate Cancer

Journal of Nuclear Medicine July 2025, jnumed.125.269729; DOI: https://doi.org/10.2967/jnumed.125.269729 ...
snmjournals.org

The Use of PSMA PET/CT Improves Overall Survival in Men with Biochemically Recurrent Prostate Cancer Treated with Salvage Radiotherapy: Real-World Data from an Entire Country

Journal of Nuclear Medicine June 2025, jnumed.125.269996; DOI: https://doi.org/10.2967/jnumed.125.269996 The present nationwide cohort study used real-world data ...
snmjournals.org

GPC3-targeted immunoPET allows for early detection of HCC: a pilot clinical study

Journal of Nuclear Medicine June 2025, 66 (supplement 1) 252173; ...
snmjournals.org

Retreatment of Metastatic Castration-Resistant Prostate Cancer Patients with

Journal of Nuclear Medicine May 2025, jnumed.125.269746; DOI: https://doi.org/10.2967/jnumed.125.269746 ...
snmjournals.org

225 Ac/ 89 Zr-Labeled N4MU01 Radioimmunoconjugates as Theranostics Against Nectin-4–Positive Triple-Negative Breast Cancer

Nectin-4 is an overexpressed biomarker in 60%–70% of triple-negative breast cancer (TNBC) cases and an ideal target for radiotherapy and PET imaging. In this study, theranostic radioimmunoconjugates ...